Pharmaceutical Technology Editors

International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.

SGS to offer program-based stability testing services for biopharmaceuticals from Wokingham, UK facility.

EMA's guidance focuses on the use of pharmacogenomics to improve drug safety monitoring.

NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.

Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.

The Committee for Medicinal Products for Human Use (CHMP) held a meeting on Jan. 20-23, 2014.

Products enable testing in accordance with methods described in new USP monograph.

FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location

Competition seeks to encourage academic research and accelerate drug delivery applications.

In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.

Teva announced an agreement to acquire NuPathe and its migraine treatment patch.

NovePen Echo is the first insulin injection device combining half-unit dosing and memory function

J&J's diagnostics business goes to global asset manager, The Carlyle Group.

InformEx, North America's business partnering event for buyers and sellers of high-value chemistry, has launched the 30th edition of its annual conference at the Miami Beach Convention Center.

Patheon will display its late-stage API development capabilities at InformEx.

Online portal accepts nominations for FDA advisory committee membership.

The Natural Product Center of Excellence seeks to identify novel active compounds for new antibiotics.

Cour Pharmaceutical Development Company, a biopharmaceutical company, has published new data showing that its proprietary nanoparticle therapy could potentially reduce inflammation and promote tissue repair and regeneration in patients who have had a heart attack.

CPhI-InformEx Report will to describe American pharma economy from European and domestic perspectives.

Mentholatum announces a voluntary nationwide recall of Rohto Eye Drops made in Vietnam.

Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.

USP opens expanded Shanghai facility to enhance quality standards for medicines and food ingredients.

The Stevens Institute of Technology will open a new biotechnology laboratory in January 2014.

A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.

An optical sensor designed by chemists at the Massachusetts Institute of Technology tracks zinc levels to gain insight on prostate cancer.

SGS will open its fifth Life Sciences Services Laboratory in Carson, California.

USP announced the approval of General Notices section 5.60.30 Elemental Impurities in USP Drug Products and Dietary Supplements with an official date of Dec. 1, 2015.

MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.

FDA releases guidance on the qualification of drug development tools.

Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.